2,5-Dimethoxy-4-amylamphetamine | |
---|---|
2-(2,5-Dimethoxy-4-pentyl-phenyl)-1-methyl-ethylamine |
|
Other names
2,5-Dimethoxy-4-amyl-amphetamine; |
|
Identifiers | |
Abbreviations | DOAM |
CAS number | 63779-90-8 |
ChemSpider | 10440619 |
ChEMBL | CHEMBL161416 |
Jmol-3D images | Image 1 Image 2 |
|
|
|
|
Properties | |
Molecular formula | C16H27NO2 |
Molar mass | 265.39 g/mol |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
Dimethoxy-4-amylamphetamine (DOAM) is a lesser-known psychedelic drug and a substituted amphetamine. DOAM was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 10 mg, and the duration is unknown. DOAM produces a bare threshold and tenseness. As the 4-alkyl chain length is increased from shorter homologues such as DOM, DOET and DOPR which are all potent hallucinogens, the 5-HT2 binding affinity increases, rising to a maximum with the 4-(n-hexyl) derivative before falling again with even longer chains, but compounds with chain length longer than n-propyl, or with other bulky groups such as isopropyl, t-butyl or γ-phenylpropyl at the 4- position, fail to substitute for hallucinogens in animals or produce hallucinogenic effects in humans, suggesting these have low efficacy and are thus antagonists or weak partial agonists at the 5-HT2A receptor.[1][2][3]